Figure 7
From: Targeted therapy against Bcl-2-related proteins in breast cancer cells
Effects of treatment with antisense Bcl-2 and mitomycin C, doxorubicin, paclitaxel, or docetaxel on ZR-75-1 cells. Enhancement of the antitumor effects of anticancer drugs by antisense Bcl-2 oligodeoxynucleotides in ZR-75-1 tumor xenografts. Each point represents the mean tumor volume of the eight mice in each group. Error bars indicate SD. *, P < 0.05, analysis of variance with Fisher's least significant difference test. The data presented are from two independent experiments. MMC, mitomycin C; DOX, doxorubicin; TXL, paclitaxel; TXT, docetaxel.